Literature DB >> 1997230

The management of malignant bone tumors in children and adolescents.

M Mercuri1, R Capanna, M Manfrini, G Bacci, P Picci, P Ruggieri, A Ferruzzi, A Ferraro, D Donati, R Biagini.   

Abstract

A series of 205 pediatric patients affected by osteosarcoma, Ewing's sarcoma, fibrosarcoma, and malignant fibrous histiocytoma of bone were treated from 1978 to 1988. Ninety-eight percent of the patients received chemotherapy and 63% had a surgical resection. Sixty-five percent of all patients were alive at 30 months and were considered disease free. The functional results after surgery were evaluated according to the Musculoskeletal Tumor Society score. In all diaphyseal resections and resections of the upper extremity and pelvis, the results were excellent or good in 60% of the cases. In resections of the proximal femur, distal femur, or proximal tibia and reconstruction with nonexpansible prostheses, the results were excellent or good in 75%. On the other hand, when arthrodeses of the lower extremity were used, only 14% of cases had a good result. This correlates with the resulting lack of articulation and serious limb shortening seen with progression of skeletal growth.

Entities:  

Mesh:

Year:  1991        PMID: 1997230

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

1.  Kinematic study of a reconstructed hip in paediatric oncology.

Authors:  F Taddei; A Stagni; M Cappello; R Manfrini; U Albisinni; M Viceconti
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

2.  A comparison of function after limb salvage with non-invasive expandable or modular prostheses in children.

Authors:  Kirsten K Ness; Michael D Neel; Sue C Kaste; Catherine A Billups; Victoria G Marchese; Bhaskar N Rao; Najat C Daw
Journal:  Eur J Cancer       Date:  2014-12       Impact factor: 9.162

3.  Physeal distraction for joint preservation in malignant metaphyseal bone tumors in children.

Authors:  Michael Betz; Charles E Dumont; Bruno Fuchs; G Ulrich Exner
Journal:  Clin Orthop Relat Res       Date:  2011-12-28       Impact factor: 4.176

Review 4.  Regenerative Medicine Approaches for the Treatment of Pediatric Physeal Injuries.

Authors:  Nichole Shaw; Christopher Erickson; Stephanie J Bryant; Virginia L Ferguson; Melissa D Krebs; Nancy Hadley-Miller; Karin A Payne
Journal:  Tissue Eng Part B Rev       Date:  2017-09-28       Impact factor: 6.389

5.  What Are the Complications of Allograft Reconstructions for Sarcoma Resection in Children Younger Than 10 Years at Long-term Followup?

Authors:  Luis A Aponte-Tinao; Jose I Albergo; Miguel A Ayerza; D Luis Muscolo; Federico Milano Ing; German L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

6.  Does increased rate of limb-sparing surgery affect survival in osteosarcoma?

Authors:  Miguel A Ayerza; Germán L Farfalli; Luis Aponte-Tinao; D Luis Muscolo
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

7.  Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection.

Authors:  William C Eward; Vasileios Kontogeorgakos; Lawrence Scott Levin; Brian E Brigman
Journal:  Clin Orthop Relat Res       Date:  2009-08-22       Impact factor: 4.176

8.  Successful management of a childhood osteosarcoma with epiphysiolysis and distraction osteogenesis.

Authors:  S F Xu; X C Yu; M Xu; X Chen
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

9.  Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults.

Authors:  Ronald R Hugate; Ross M Wilkins; Cynthia M Kelly; Walt Madsen; Ioana Hinshaw; Anne B Camozzi
Journal:  Clin Orthop Relat Res       Date:  2008-04-25       Impact factor: 4.176

10.  Allograft reconstruction after sarcoma resection in children younger than 10 years old.

Authors:  D Luis Muscolo; Miguel A Ayerza; Luis Aponte-Tinao; German Farfalli
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.